Snapshot A 35-year-old woman presents to the emergency room for an ulcer on her arm. She reports that she recently completed a travel program in Africa, where she worked on the farms in exchange for room and board. She reports coming into contact with farm animals every day. She said she accidentally cut her left forearm on some wooden post a few days ago. Yesterday, she noticed a painless but pruritic lesion. On physical exam, there is a 4-mm papule with a dusky-looking central vesicle and surrounding edema. There is also axillary lymphadenopathy. She is started on antibiotics. Introduction Classification Bacillus anthracis spore- and exotoxin-forming gram + rod capsule protects against phagocytosis login to view 1 more bullet transmission inhalation of spores introduction of spores into a skin break ingestion of spores Epidemiology incidence more common in areas where animal vaccination rates are low bioterrorism risk factors intravenous drug use (e.g., heroin) occupational exposure to unvaccinated animals occupational exposure to animal hides Pathogenesis anthrax toxin composed of 3 components protective antigen login to view 1 more bullet edema factor login to view 3 more bullets lethal factor login to view 1 more bullet infection may spread via lymphatics Associated conditions cutaneous anthrax most common pulmonary anthrax “woolsorter’s disease” gastrointestinal anthrax Prevention post-exposure prophylaxis 3 doses of anthrax vaccine 60 days of a single antibiotic login to view 1 more bullet Prognosis biphasic nature of pulmonary anthrax prodromal symptoms fulminant bacteremic phase login to view 1 more bullet Presentation Symptoms pulmonary anthrax flu-like syndrome with non-productive cough nausea and vomiting hemoptysis chest pain gastrointestinal anthrax nausea and vomiting dysentery abdominal pain Physical exam cutaneous anthrax initial lesion is a painless and pruritic papule with a central vesicle or bulla this progresses to painless and necrotic black eschar login to view 1 more bullet eschar sloughs off at day 14 pulmonary anthrax mediastinitis shock hypoxia dyspnea lymphadenopathy Imaging Chest radiography indication pulmonary anthrax findings pleural effusion pulmonary consolidation widened mediastinum Studies Labs multiple methods of detection “medusa head” appearance on microscopy login to view 1 more bullet culture of blood, pleural fluid, or eschar positive Gram stain of affected tissue polymerase chain reaction anti-protective antigen immunoglobulin G on enzyme-linked immunosorbent assay biopsy with immunohistochemistry staining marked hemoconcentration Making the diagnosis most cases are diagnosed clinically and confirmed with positive culture, serology, or immunohistochemistry detection of Bacillus anthracis DNA in tissue Differential Community-acquired pneumonia distinguishing factor less likely to have nausea, vomiting, pallor, or unexplained mediastinal widening on chest radiography Treatment Management approach antibiotics should be given in the prodromal phase of the disease cutaneous anthrax can be treated with 1 antibiotic systemic anthrax can be treated with 2 antibiotics Medical ciprofloxacin or doxycycline indication login to view 1 more bullet protein synthesis inhibitor indications login to view 2 more bullets mechanism login to view 1 more bullet drugs login to view 2 more bullets antitoxins indication login to view 1 more bullet drugs login to view 3 more bullets Complications Bacteremia from cutaneous anthrax Death